Neuromedin U ‘Innervation’ Reprograms Myeloid Immunosuppression in Neuroendocrine Prostate Cancer

Using a transgenic mouse model, researchers showed that early stages of neuroendocrine prostate cancer are associated with increased intraprostatic recruitment of Ly6G+ polymorphonuclear neutrophils and reduced infiltration of CD8+ T cells.